These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 10181516)

  • 1. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
    Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices; preemption of state product liability claims--FDA. Correction.
    Fed Regist; 1997 Dec; 62(242):66179. PubMed ID: 10179302
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preemption and medical devices: a response to Adler and Mann.
    Hermann M; Ritts GJ
    Food Drug Law J; 1996; 51(1):1-19. PubMed ID: 11794345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Safe Medical Devices Act of 1990--FDA. Notice.
    Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; device tracking--FDA. Final rule; suspension of effective date; notification of status under the Safe Medical Devices Act; technical amendments.
    Fed Regist; 1993 Aug; 58(156):43442-51. PubMed ID: 10127886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1992 May; 57(104):22966-70. PubMed ID: 10171013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
    Jarcho DG
    Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Jul; 63(147):40825. PubMed ID: 10181716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.
    Fed Regist; 1998 Sep; 63(170):46718. PubMed ID: 10182705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.